Sophorolipid Candidates Demonstrate Cytotoxic Efficacy Against 2D and 3D Breast Cancer Models
C. L. Roberge, R. T. Miceli, L. R. Murphy, D. M. Kingsley, R. A. Gross, D. T. Corr
This study evaluates two sophorolipid candidates against 2D and 3D breast cancer models, finding one sophorolipid has comparable cytotoxicity to doxorubicin, with higher resistance in 3D spheroids.
bioRxiv · Sep 1, 2022 · PreprintPharmacology & Toxicology